Among the biggest challenges to containing the ongoing pandemic of
Read moreSARS-CoV-2 variants emerge during humoral immunity phase of acute COVID-19
Home » Coronavirus Disease COVID-19 »
Mucosal delivery of IFNs a good strategy for COVID-19 prophylaxis post-exposure
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the betacoronavirus responsible
Read moreSARS-CoV-2's resistance to remdesivir in vitro
With over 108 million reported infections from severe acute respiratory
Read moreSecond dose of Pfizer-BioNTech COVID-19 vaccine may not benefit previously infected individuals
Researchers at the NYU Grossman School of Medicine have shown
Read moreFred Hutch researchers predict a 4th wave of SARS-CoV-2
The COVID-19 pandemic has taken a profound toll on human
Read moreScientists produce active antigen in bacteria to help combat SARS-CoV-2
Caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2),
Read moreIs a ten day isolation period for COVID-19 patients long enough?
During the first wave of the coronavirus disease 2019 (COVID-19)
Read moreCan early use of colchicine reduce COVID-19 mortality?
The coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute
Read more